Celanese: UBS raises target price to $58 from $53
CE•UBS raised its target price for Celanese to $58 from $53.
Related News
Lantern Pharma plans Phase 1b/2a trial of LP-184 plus spironolactone in recurrent glioblastoma
LTRN•
Alliance Entertainment announces exclusive distribution partnership with JAKKS Pacific
JAKK•
Ionis Pharmaceuticals: Oppenheimer cuts target price to $70 from $85
IONS•
Virginia National Bankshares declares 8% stock dividend
VABK•
US research roundup: Cabot, Ionis Pharmaceuticals, Tesla
IONS•